Shanghai Deji Hospital
Shanghai Deji Hospital — Shanghai
Hospital Profile
Shanghai Deji Hospital (Qingdao University Shanghai Brain Medical Center / Qingdao University Shanghai Clinical Medical College) opened in 2013. It is a key livelihood project in Putuo District under the “Twelfth Five-Year Plan,” invested and constructed by the Columbia University Foundation in the United States. In 2016, it became a member institution of Lenovo Holdings, ranked among the Fortune Global 500. The hospital is a tertiary-scale private/China-foreign joint venture specialized brain hospital. It is a designated hospital within the national medical insurance network and one of the first national medical insurance network hospitals. As a teaching hospital of a key university, it has qualifications for recruiting postdoctoral researchers (located at the Putuo District Postdoctoral Innovation Practice Base) and offers master's and doctoral training programs. It has been awarded honors such as “Shanghai Civilized Unit” and “Civilized Unit of Shanghai Health and Family Planning System,” and has fulfilled social responsibilities through epidemic prevention efforts as well as various targeted aid and charitable activities.
Medical Milestones
• 2013: The hospital was established and opened. • 2016: Became a member institution of Lenovo Holdings, a Fortune Global 500 company. • 2017: Became Qingdao University Shanghai Clinical Medical College/Qingdao University Shanghai Brain Medical Center; took the lead in introducing Shanghai's and East China's first ROSA surgical robot. • 2021: Praised by the Director of Shanghai Municipal Health Commission as "the social-run hospital with the strongest expert technical strength in the city." • 2022: Took the lead in introducing Shanghai's first 512-slice multimodal advanced research CT. • 2023: Joined the national major research project "China Brain Atlas Program" as one of the main participants; the Cardiovascular Center was rated as a national heart failure center. • 2024: Obtained national postdoctoral recruitment qualification; the Cardiovascular Center was rated as a Chinese Atrial Fibrillation Center construction unit; established the Fudan University-Deji Brain Science Research Achievement Transformation Fund; introduced the US GE ultra-high-end research MRI. • 2025: 2 postdoctoral fellows successfully started their positions (including Shanghai's first "super postdoctoral" in a social-run hospital); held the "National Clinical EEG Practical Basic Theory and Operation Training Course" for the ninth consecutive year, and the "systematic SEEG technology" Deji program was specially interviewed by Xinhua News Agency.
Key Capabilities & Patient Care
Adhering to the philosophies of 'Do the best, Be the best, master the finest medical skills, and become the most outstanding doctor' and 'Be the hospital with the highest employee happiness.' As a demonstration base for emergency services, it undertakes the largest 120-emergency station rescue missions in northwest Shanghai (serving 1.2 million permanent residents). Actively engaging in public welfare, including recruiting for charitable neurosurgeries in Yunnan and other regions, assisting impoverished patients, responding to collaborations between the Yangtze River Delta and eastern-western regions, and as a surgical implementation unit, completing over 200 orthopedic public welfare surgeries in cooperation with the China Disabled Persons' Federation.
Advanced Technology
Introduced the first ROSA surgical robot in Shanghai and six provinces of East China, ushering in the era of neurosurgical robotic surgery in Shanghai; equipped with a 512-slice multimodal advanced research CT, US GE ultra-advanced research MRI, hyperbaric oxygen chamber, and AI rehabilitation robots; has a neuroelectrophysiology center surpassing Japan's Shizuoka National Epilepsy Hospital (EEG reports are recognized and accepted worldwide). Proficient in ROSA robotic surgery, DBS surgery (more than 150 cases annually), ketogenic diet therapy, stem cell technology, brain-computer interface technology, patent foramen ovale (PFO) closure surgery, high-difficulty level-four surgeries (over 80%), and stroke thrombolysis and thrombectomy. Statistics: • Bed capacity: Total of 350 beds, authorized beds 255 (some basic information shows authorized beds as 330) • Inpatient and elective surgeries: Over 2,000 surgeries annually; more than 3,700 epilepsy surgeries; over 150 DBS surgeries performed annually • Department count: Focus on developing Epilepsy Center, Neurosurgery (including brain tumor and spinal tumor specialized departments), Functional Neurosurgery, Neurology (including cerebrovascular disease specialized department and neuro-immunology center), Neurorehabilitation, Neuropsychology, Cardiovascular Treatment Center (Cardiology), Emergency and Critical Care Medicine Center, as well as Internal Medicine, General Surgery, Orthopedics, Wound Repair, Traditional Chinese Orthopedics, Medical Nutrition, etc. • Number of doctors and specialist physicians: 1 current national chairman, 1 former national chairman, 10-16 national committee members, 14-16 Shanghai committee members; 3 doctoral supervisors and 14-16 master's supervisors; all department heads hold doctoral degrees; founder Professor Guo Hui is an internationally recruited expert; hospital president is Professor Che Xiaoming
International Patient Services
Invested and constructed by the Columbia University Foundation in the United States, it is the first Sino-foreign joint venture hospital approved by the Shanghai municipal government; the EEG report conclusions from the Epilepsy Center are recognized and accepted worldwide; the level of epilepsy surgery is among the international advanced standards. (Note: The text does not specifically mention independent service departments for international visitors, such as special needs or international departments)